Philips & Massachusetts Institute of Technology Team up to Make Managing Brain Injuries Less of a Headache for Doctors & Pati...
September 30 2015 - 2:00PM
Business Wire
Research project combines ultrasound technology, computer
modeling & neurosurgery experts to find a better way to measure
intracranial pressure from the football field to the
battlefield
Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has
teamed up with the Massachusetts Institute of Technology (MIT) to
research the use of Philips ultrasound technology and MIT
physiological modeling as a less invasive way to measure
intracranial pressure (ICP), an essential tool in managing patients
with brain injuries. It could also allow doctors to use the
measurement on less critical patients, who might not normally be
considered for such monitoring. During the study, Philips will work
with leading experts in the field of neurosurgery to test a core
estimation algorithm that has been developed by the Integrative
Neuro-monitoring and Critical Care Informatics Group in MIT’s
Institute for Medical Engineering and Science (IMES).
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20150930006523/en/
Philips mobile ultrasound technology to
help researchers find a non-invasive way to measure intracranial
pressure, as essential element in determining brain injuries.
(Photo: Business Wire)
Today’s standard ICP measurement procedures require surgical
penetration of the skull or lumbar spine and insertion of a
catheter into the cerebrospinal fluid space or neural tissue posing
a high risk of infection and damage to vital brain structures. Due
to the invasive nature of the procedure, only a small number of
patients who may require ICP monitoring are typically tracked and
benefit from it – often those suffering from the most severe head
injuries. This trial could create the opportunity to take ICP
measurements in an expanded group of patients who would not
routinely be monitored because of the health risks involved with
measuring ICP.
“The current invasive method of measuring ICP is used only in
the sickest patients, but knowledge of ICP is potentially important
in a much broader population,” says Thomas Heldt, the Hermann L.F.
von Helmholtz Career Development Professor at MIT's IMES and
assistant professor in MIT’s Department of Electrical Engineering
and Computer Science, who is principal investigator of the study.
“Our goal is to develop a noninvasive method of measuring ICP that
could be used in treating a much wider range of conditions. This
project gives us an exciting opportunity to test innovative
hardware and modeling techniques at the bedside in real time."
Over the next two years, Philips will work with MIT to research
a fully non-invasive and calibration-free approach to estimating
ICP and thereby enable better diagnosis and triage in cases where a
patient has suffered a brain injury (football field, ambulance,
battlefield, and emergency room). Using Philips portable ultrasound
technologies and monitoring technologies, as well as the MIT
model-based estimation approach, researchers hope to get the value
of ICP without penetrating the skull. Further, researchers hope to
expand the use of the technology to non-traditional patients, such
as those with unexplained headaches, mild and moderate traumatic
brain injury, or even coma patients, who normally would not have
access to this type of procedure, but who could potentially benefit
from it.
Philips recently announced the opening of its new Philips
Research headquarters for North America in Cambridge,
Massachusetts, where it will perform these types of research
projects in close collaboration with local academic and healthcare
partners. Focused on understanding how medical technologies can be
adapted to tackle some of society’s most pressing issues, Philips
hopes that this type of research can lead to meaningful innovations
that can help reduce care costs and improve patient results.
“Today it is very difficult to gauge the level of head trauma
someone has sustained at the scene of an incident, because there is
no quick and effective way to gauge the pressure inside the skull,”
said Dr. Joseph Frassica, Chief Science Officer of Philips Research
North America. “Through this research, we hope to use the same
technology most people associate with the first images of their
child, in a way that has the potential to help us to differentiate
a concussion from a serious traumatic brain injury and everything
in between. Whether you’re a high school football player, in the
NFL, a soldier in the battlefield, or unfortunate enough to be
injured in an auto accident – we hope that this technology will
give first responders a better way to determine if you have a
life-threatening brain injury and allow faster and more accurate
triage and treatment. By improving access and response times, these
types of solutions have the potential to really impact patient
outcomes.”
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company, focused on improving people’s lives through
meaningful innovation in the areas of Healthcare, Consumer
Lifestyle and Lighting. Headquartered in the Netherlands, Philips
posted 2014 sales of EUR 21.4 billion and employs approximately
108,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150930006523/en/
Philips North AmericaLea Armstrong, +1-978-659-3467Public and
Media Relationslea.armstrong@philips.com
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024